Replies to post #534494 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

LOL. Then when it get's approved. "Well it is approved, but it is too complicated, or too expensive, or patients will not want it"

lol exactly that will be ex next argument after DCVAXL is approved.

[drugrunner]

Trader JOSE already shifted his argument that it’s too expensive lol when it’s projected to be far less than many established chemo drugs

There are many CHEMO meds in the 50-150k per year…

So that argument is pure folly

[antihama]

So true, yet the beanie will not become obsolete. After therapy w murcidencel, they, w/o any alternatives at this time, and they can afford it, might try the beanie. Even. in the future, after combo therapies w murcidencel are developed that may greatly improve efficacy but not cure GBM, they might want to try the beanie. It was interesting reading the JA regarding the beanie and DCVax-L

Eight of the 232 patients (3.4%) receiving DCVax-L were treated with tumor-treating fields (TTF) following recurrence. Four of those 8 patients (50.0%) continued receiving DCVax-L while using the TTF device after recurrence and survived from 22.6 to more than 72.7 months from randomization. Four of the 8 patients (50.0%) stopped receiving DCVax-L while using the TTF device post-recurrence, and survived from 8.9 to 29.2 months from randomization.